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Abstract 
Background: Osteomyelitis is a complex disease. Treatment involves a combination of bone 
resection, antimicrobials and soft-tissue coverage. There is a difficulty in unifying a classification system 
for long bone osteomyelitis that is generally accepted. 
Objectives: In this systematic review, we aim to investigate the classification systems for long bone 
osteomyelitis that have been presented within the literature. By doing this, we hope to elucidate the 
important variables that are required when classifying osteomyelitis. 
Methods: A complete search of the Medline, EMBASE, Cochrane and Ovid databases was undertaken. 
Following exclusion criteria, 13 classification systems for long-bone osteomyelitis were included for 
review. 
Results: The 13 classification systems that were included for review presented seven different variables 
that were used for classification. Ten of them used only one main variable, two used two variables and 
one used seven variables. The variables included bone involvement (used in 7 classification systems), 
acute versus chronic infection (used in 6), aetiopathogenesis (used in 3), host status (used in 3), soft 
tissue (used in 2), microbiology (used in 1) and location of infected bone (used in 1). The purpose of 
each classification system could be grouped as either descriptive (3 classification systems), prognostic 
(4) or for management (4). Two of the 13 classification systems were for both prognostic and 
management purposes.  
Conclusions: This systematic review has demonstrated a variety of variables used for classification of 
long bone osteomyelitis. While some variables are used to guide management and rehabilitation after 
surgery (e.g., bone defect, soft tissue coverage), others were postulated to provide prognostic 
information (e.g., host status). Finally, some variables were used for descriptive purposes only 
(aetiopathogenesis). In our view and from today’s perspective, bone involvement, antimicrobial 
resistance patterns of causative micro-organisms, the need for soft-tissue coverage and host status are 
important variables to include in a classification system. 
Key words: Long-bone osteomyelitis, Classification, Bone and Joint Infection. 
Introduction 
Osteomyelitis describes infection and 
inflammation of bone.1,2 Treatment strategies includes 
the combination of antibiotics,3 surgical resection4,5 
and soft-tissue coverage.6 Ultimately, this has resulted 
in a specialist multi-disciplinary approach to 
diagnosis and treatment.7–9 Despite these advances, 
osteomyelitis is still a clinical challenge from 
diagnosis to long-term management. The challenges 
and inherent complexities of osteomyelitis have 
resulted in difficulties defining a classification system 
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or offering a distinction between chronic and acute 
disease.10–12  
The two most well-known classification systems, 
the Cierny-Mader and the Waldvogel,13–16 are over 30 
years old. Since these were presented, there have been 
considerable advances in osteomyelitis treatment 
strategies and management options. In recent years, 
new classification systems have been introduced. 
However, they are not widely used owing to 
complexity and lack of evidence supporting their 
clinical effectiveness.17,18 Subsequently, there is no 
uniformly accepted classification system for long 
bone osteomyelitis. 
The aim of this systematic review is to 
investigate existing classification systems for long 
bone osteomyelitis within the literature. The variables 
used within these classification systems and outcome 
data in association with the corresponding 
classification will be assessed. Finally, we will discuss 
the significance of identified variables for the 
management of the long bone osteomyelitis from 
today’s perspective.  
Methods 
Electronic resources 
The MEDLINE, EMBASE, Ovid and Cochrane 
databases were searched from their date of 
development. The study was registered on the 
PROSPERO database and the protocol can be accessed 
at the following web address.19  
Classification Systems Included 
Data was collected on classification systems of 
long-bone osteomyelitis in both adults and children. 
Classification systems were included if they used new 
approaches of classifying or categorising 
osteomyelitis. Those that only reported a scoring 
system for indicating the probability of a positive 
diagnosis of osteomyelitis were excluded from the 
review. 
Selection Strategy and Criteria 
Search terms were chosen by performing 
preliminary literature searches. Search terms included 
“bone infection”, “osteomyelitis”, “classification”, 
“staging” and “scoring”. A full search strategy is 
shown in figure 1. Duplicate studies and those not 
published in English were then excluded. Following 
this, records that were not relevant to long-bone 
osteomyelitis (predominantly those regarding 
maxillofacial osteomyelitis, diabetic foot, spinal 
osteomyelitis or chronic recurrent multifocal 
osteomyelitis) were excluded. Any animal in vivo or in 
vitro studies were excluded. There was no minimum 
follow up period for the included studies. All levels of 
evidence except case reports were included for 
review. The references from the included studies were 
screened and any relevant studies were included for 
review. 
Data Extraction 
Demographic data were extracted from the 
studies which included number of patients in the 
validation, follow up details and patient age ranges. 
Each of the specific variables used for classification 
was reviewed. Definitions of acute and chronic 
osteomyelitis were also noted. 
Study Selection 
A total of 336 studies were returned from 
database searches. Through further reading and 
references, additional 7 studies were also included 
(i.e., n = 343). There were 144 duplicate studies that 
were removed from the results. Then, 145 
publications that did not meet the inclusion criteria 
were excluded based on their title (i.e., n = 54). The 
reviews and case reports were then excluded based on 
the title and the abstract. One conference abstract 
proved difficult to obtain and was therefore 
excluded.20 Full text articles were retrieved for 26 
publications. Of these, 13 were excluded because 8 
were studies using previous classification systems, 
and 5 were for diagnostic purposes. This process is 
shown in figure 1. Thus, 13 studies met the inclusion 
criteria and were reviewed.  
Results 
1. Study Demographics 
A summary of the studies included are shown in 
table 1. All included studies had their classification 
systems described in patient cohorts, either 
prospectively or retrospectively. The mean number of 
patients used to validate the classification systems 
was 158 (range 14 – 425). Of the 13 studies, 4 were 
intended for prognostic purposes,21–24 4 for guiding 
management strategy,25–28 and 2 were for prognosis 
and guiding management.16,17 Three classifications 
were not intended for clinical use and did not report 
outcomes (i.e., for descriptive purposes only).10,13,29 
Seven studies reported time scales of patient 
follow-up (between 6 and 41 months).16,17,21–23,25,28 
2. Variables 
In the 13 classification systems that were 
reviewed, the variables used for classification 
included bone involvement (2.2.1), acute or chronic 
infection (2.2.2), aetiopathogenesis (2.2.3), host status 
(2.2.4) soft-tissue coverage (2.2.5), anatomical location 
(2.2.6.) and micro-organisms (2.2.6) (Table 1).  
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Table 1. The 13 included classification systems and the variables each that were described in each.  
Year, author Cases 
described 
No. of 
Variables 
Aetio-pathogenesis Bone 
involvement 
Soft-tissue Host 
Co-morbidity 
Anatomical 
location 
Micro-organism Acute vs 
chronic 
Purpose 
1970, Waldvogel13–15 248 1 ● (all) - - - - - + Des 
1982, May21 22 1 PT - +/- - - - ● Pro 
1984, Weiland22 33 1 PT ● +/- - - - - Pro 
1984, Ceirny & 
Mader16 
189 2 All ● - ● - - - Man / Pro 
1988, Gordon23 14 1 PT ● +/- - - - + Pro 
1989, May and 
Jupiter24 
250 1 PTT ● - - - - * Pro 
1990, Kelly29  425 1 ● (all) - - - - - * Des 
1994, Lauschke25 55 1 H - - - - - ● Man 
2003, Solagberu26 271 1 All - - - - - * Man 
2009, Jones27 87 1 H ● - - - - + Man 
2011, Romano10 300 7 ● (all) ● ● ● ● ● ● Des 
2013, Yang28 51 1 PT +/- ● - - - - Man 
2015, Marais17 109 2 All ● - ● - - - Man / Pro 
● = used as a true / primary variable. This is defined as a variable that the classification is based upon. PT = post-traumatic osteomyelitis. PTT = post-traumatic tibial 
osteomyelitis only. H=Haematogenous osteomyelitis. All = all types of osteomyelitis. +/- = partially used. Des = descriptive. Pro = prognostic. Man = Management. 
+=defined, not used. * =used, not defined. 
 
2.1. Number of variables 
One of the 13 classification system used 7 
variables and two systems used two variables for 
classification. Ten classification systems used only one 
variable. Seven of these 10 used a selection criterion to 
determine eligibility for classification (for example 
specifying that the classification was for 
post-traumatic osteomyelitis only or involving free 
flap soft tissue reconstruction). 
2.2. Purpose and sub-classification of variables 
2.2.1. Bone Involvement 
Seven classification systems used the bone 
involvement as the main variable for classification, 
with two of these classification systems being 
dedicated solely to post-traumatic osteomyelitis in 
patients who needed free flap coverage. The 
sub-classification of the variable was either the 
pattern of bone involvement (medullary, superficial, 
diffuse, localised),16,17 stability of the bone,17 the extent 
of bone involvement10,22–24 or radiological presence of 
abscesses, sequestrum and sclerosis.27 One 
sub-classification used the extent of bone 
involvement, which specified that all patients needed 
a bone defect larger than 3 cm to be classified.28 
2.2.2. Acute versus chronic osteomyelitis 
Six classification systems used this variable and 
gave a definition for acute and chronic osteomyelitis. 
In three further classification systems the descriptive 
terms ‘acute’ or ‘chronic’ were used but not defined. 
In non-haematogenous osteomyelitis, the transition 
from acute and chronic disease ranged from 2 weeks 
to 6 months. One classification system defined chronic 
osteomyelitis as being present when there was a 
previous admission for the same disease.13 Two 
classification systems, both of which were 
classifications of the soft-tissue status, used the 
duration of a draining sinus as a marker for acute and 
chronic disease.21,23 Two classification systems for 
haematogenous osteomyelitis differed in their time 
frame for acute and chronic disease, varying from 
using days25 to months.27  
2.2.3. Aetiopathogenesis 
Three classification systems defined 
aetiopathogenesis as one of the primary variables and 
were for descriptive purposes in all types of 
osteomyelitis. Waldvogel classified aetiopathogenesis 
into three categories (haematogenous, contiguous and 
secondary to vascular insufficiency).14 Kelly used four 
categories which were haematogenous, secondary to a 
united fracture, secondary to a non-united fracture 
and post-orthopaedic procedure.29 Romano used five 
categories which were haematogenous, secondary to 
vascular disease, secondary to trauma, with a 
temporary implant (further classified as type I, II or 
III) or with permanent implant. Seven classification 
systems used aetiopathogenesis to determine 
eligibility for classification and not as a primary 
variable. Of these, four were for post-traumatic 
osteomyelitis21–24,28 and one was specifically for 
infected tibial non-union.23 Two classification systems 
were designed for haematogenous osteomyelitis in 
children.25,27 Finally, in the three classification systems 
for all types of osteomyelitis, the term 
aetiopathogenesis was used but not defined.16,17,26 
2.2.4. Classification of Host Status 
Three classification systems classified the host 
status.10,16,17 Cierny and Mader classified the host into 
three broad categories, (A) patients who were fit for 
surgery, (B) patients who were fit for surgery but with 
either systemic or local compromise and (C) those 
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who were not fit for surgery. The Marais classification 
built on this method by specifying a points system for 
entry into each category, with major and minor 
criteria.17 The Romano classification system used a 
similar system to the Cierny and Madder but 
specified whether the patient was an adult, child (<14 
years) or infant (<2 years).10 
2.2.5. Classification of the Soft-tissues 
Two classification systems used the soft tissue 
status as the primary variable for classification and 
subclassified clinical cases further by the size of the 
soft tissue defect.10,28 They related the size of the soft 
tissue defect in centimeters to prognosis. Three 
classification systems which were all for 
post-traumatic osteomyelitis specified the soft tissue 
defect in their classification.21–23 May et al.21 specified 
the presence of a draining sinus. Both Weiland et al.20 
and Gordon et al.21 specified that the defect should be 
large enough to need free flap tissue transfer for 
reconstruction. 
2.2.6. Anatomical Location and Micro-organism 
The only classification that has used anatomical 
location of the infection and involved the type of 
micro-organism is Romano’s seven item classification 
system.10 The anatomical location was divided into 
spine, hand, long bone, foot or joint infection. The 
microbiology was divided into Gram-positive or 
Gram–negative bacteria, polymicrobial growth, 
presence of mycobacteria, fungal organisms or no 
growth. The benefit of classifying by using these 
variables was not reported. 
Discussion 
Over the past 45 years, multiple classification 
systems for long bone osteomyelitis have been 
proposed within the literature. Using a 
comprehensive search, 13 individual classification 
systems were retrieved, all of which use a different 
approach to the classification of osteomyelitis. As of 
yet, none are uniformly accepted or widely clinically 
used. In the next paragraphs, we will discuss the 
variables and their sub-classification found in this 
review in comparison to views from today’s 
perspective. 
Bone involvement 
In the Cierny and Mader classification, the 
pattern of bone involvement was used to guide 
surgical treatment strategy.16 Interestingly, the pattern 
of bone involvement had little correlation with 
prognosis at 2-year-follow-up amongst surgical 
candidates.30 Although the Cierny and Mader16 
anatomical classification did not have a bearing on 
prognosis, the location within the bone may play a 
role. One study demonstrated the importance of the 
location of the infection within the bone of children. In 
meta-epiphyseal disease 53% (8/15) had relapse 
compared to none of the 72 children who had 
non-meta-epiphseal involvement.31 A similar study 
with adults has not been reported within the 
literature.  
It is paramount to include bone involvement in 
an osteomyelitis classification. The variable can be 
classified either by stability, type of defect (segmental 
versus cavitary), location of infection in the bone 
(relation to the physis), the anatomical pattern of 
infection (medullary, superficial, localised or diffuse), 
or by defining the extent of bone that has been or has 
to be resected. Patients with larger, unstable defects 
(more often segmental) have a poorer prognosis 
compared to patients who have small, stable defects 
(more often cavitary).9 Gordon23 and Romano10 used a 
3 cm bone defect and May and Jupiter24 used a 6 cm 
defect for their classification. The optimal 
sub-classification of the variable bone involvement 
needs to be elucidated.  
Acute versus chronic infections 
Multiple definitions between acute and chronic 
osteomyelitis exist, although these vary between 
authors.10,13,21,23,25,27 These definitions are based either 
on time scale or the presence of necrotic bone. 
However, making this distinction in clinical practice 
can be difficult and unreliable. Knowing the exact 
starting point of the infection is impossible except in 
some cases when infection presents shortly after 
injury or surgery. More importantly, the terms acute 
and chronic do not have a strong influence on the 
diagnostic work-up or the principles of medical or 
surgical management. Necrotic bone should be 
removed surgically, irrespective of whether the 
disease is ‘acute’ or ‘chronic’. Therefore, from today’s 
perspective, it would be reasonable to remove these 
terms from a classification system for long bone 
osteomyelitis. Another argument is that it does not 
alter the duration or choice of antimicrobial treatment. 
Traditionally, it was thought that acute bone 
infections should be treated for 6 weeks or less, and 
chronic infections for 3 months.32,33 However, this 
recommendation is not based on the results of a 
clinical trial. Moreover, this treatment duration may 
not be adequate for patients who experience a 
curative surgical procedure. For example, the 
treatment duration can be short after surgery for 
osteomyelitis (i.e., following complete removal of 
necrotic bone), despite the fact that the disease was 
‘chronic’. In addition, the expected duration of 
antimicrobial treatment should not influence whether 
surgery should be performed. Even without surgical 
 J. Bone Joint Infect. 2017, Vol. 2 
 
http://www.jbji.net 
172 
procedure the recommendation may be inadequate. 
For example, patients not fit for surgery can be treated 
for a long period without cure (for example, 
suppressive treatment). On the other hand, chronic 
osteomyelitis without systemic inflammatory signs 
may not require antimicrobials (for example, in the 
presence of a sinus tract, dormant bacteria or low 
grade clinical presentation). Thus, using the terms 
acute and chronic does not determine the need for or 
the duration of antimicrobial treatment. 
Aetiopathogenesis 
Classification of osteomyelitis by aetiopatho-
genesis alone is unable to offer detailed information 
on management or prognosis. Most published series 
describe cases as either haematogenous, 
post-traumatic or secondary to co-morbidity 
associated soft-tissue defects (for example ulcers in 
diabetic foot syndrome). By using this as a basis, the 
most simplistic and appropriate method for 
describing osteomyelitis is either as exogenous 
(referring to post-traumatic, post-operative or 
following bone exposure to a non-sterile 
environment) or endogenous (haematogenous). 
Waldvogel et al.14 classified osteomyelitis irrespective 
of anatomic localization and Kelly et al.29 classified 
only tibial and femoral disease. Both authors defined 
haematogenous osteomyelitis as a separate entity to 
osteomyelitis arising from external sources. Kelly et 
al.29 classified the exogenous osteomyelitis into three 
subcategories dependent on the presence of a fracture 
and whether this fracture was united or not. 
Exogenous osteomyelitis encompasses an exposure to 
the surrounding environment either through a break 
in the skin or from direct spread from local soft 
tissues. This can range from an iatrogenic procedure 
to an ulcer that allows the entrance of 
micro-organisms that can cause infection in the bone.  
Although classification of osteomyelitis by 
aetiopathogenesis alone is useful in describing the 
history of the disease, in our view, it is unlikely to be 
able to guide treatment in adults or give information 
on prognosis. 
Host Status 
Patient co-morbidity is thought to play a role in 
both guiding appropriate surgical strategies as well as 
giving an indication of prognosis to patients.30,34 
Cierny and Mader first categorised host status 
dependent on medical co-morbidity.16 Long-term 
follow up showed that increasing medical 
co-morbidity did correlate with increased recurrence 
of infection and need for further treatment.30 This was 
supported in a 50-patient series which observed 
longer hospital stays for B hosts when compared to A 
hosts (12.3 days versus 7.1 days). However, there was 
no difference in recurrence at mean follow up of 3.2 
years.35 This difference in longer hospital stays could 
be due to the subjective nature of host B and C 
stratification. In an attempt to remove this 
subjectivity, a different approach to host status 
classification was proposed in 2002.18 McPherson built 
on the Cierny and Mader classification by defining 
criteria for each A, B and C hosts. These criteria were 
designed for implant-associated infection rather than 
osteomyelitis, although it was thought to be 
applicable to osteomyelitis.10 Using this method, a 
series of 50 patients with implant-associated 
infections were followed up over an average of 23.3 
months. All of the post-operative deaths were in those 
defined as C hosts (5/50). There was a correlation 
between systemic host grade and having one or more 
complication, amputation or exchange of the foreign 
body. In addition to McPherson, Marais has proposed 
a modification to the host status described by Cierny 
and Mader.17 Here, the definition for A, B and C hosts 
were dependent on the number of major and minor 
risk factors. In contrast to the Cierny and Mader 
classification system where host status may predict 
outcome and define suitability for surgery, the Marais 
classification was unable to predict prognosis in the 
cohort used.17 From today’s perspective, recent 
advances in medical treatment have meant that 
previously untreatable diseases are now optimisable 
or curable. One specific example of this is the 
improvement of outcomes in prosthetic joint infection 
following the introduction of highly active 
anti-retroviral therapy in patients with Human 
Immunodeficiency Virus.36 To accommodate ongoing 
advances in the treatment of chronic diseases and 
treating patient’s co-morbidities, the use of host status 
in an osteomyelitis classification system needs to be 
tailored to factors that adapt accordingly with medical 
progress. These factors therefore must assess the risk 
of surgery, and hence, influence the decision on 
management, and preferably predict the outcome. 
Soft-tissue classification 
The extent of soft tissue defect in osteomyelitis 
has been categorised by both duration of skin sinuses 
and size of the defect. The importance of achieving 
soft tissue coverage in osteomyelitis has been 
reported.37–39 The success of soft tissue restoration 
techniques relies on the state of surrounding soft 
tissues and this will dictate the need for direct closure, 
local flap or free flap cover. However, not all cases 
that are treated with bone debridement require 
complex soft tissue reconstruction.38,40 The May 
classification described the success of soft tissue 
coverage rather than the resolution of the bone 
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infection.37 For larger soft tissue defects, the Yang 
classification classified three distinct sizes (less than 
10x20cm, more than 10x20cm and with limb 
shortening of 3cm or more) and presented an option 
for management of each one.28 The soft tissue 
compromise present in osteomyelitis will therefore 
vary on an individual basis. If managed correctly, 
using appropriate soft tissue reconstruction 
techniques, the osteomyelitis can have a good 
prognosis.  
Micro-organisms 
There is little evidence within the literature 
regarding correlation between causative organism 
and prognosis in osteomyelitis, although there have 
been epidemiological changes in the most prevalent 
organisms in recent years.41 Romano’s 2011 
classification is the only classification system to 
incorporate causative organism.10 It is suggested that 
different organisms require different clinical 
approaches. In our experience, this is not the case 
except in mycobacterial osteomyelitis where samples 
may need specific culture mediums42 and can be 
treated with antibiotic therapy alone.43,44 Romano’s 
classification may be intended for descriptive 
purposes only, and to the best of our knowledge, has 
not been validated clinically. Others reported that the 
number and type of organism are reported not to have 
a bearing on the outcome of treatment.16 Although, 
some micro-organisms, Staphylococcus aureus in 
particular, are able to reside in the bone in a dormant 
state after an episode of osteomyelitis. After this, they 
may reactivate many years later despite adequate 
surgical and antimicrobial treatment.45,46 In addition, 
the recent changes in causative organisms and 
increased bacterial resistance will likely have an 
impact on clinical outcome. However, there are 
currently no data proving this theory.41 It has been 
demonstrated that there is an improvement in 
outcome when using a specialist musculoskeletal 
infectious disease consultant, suggesting specialist 
input in microbial management is an important aspect 
of managing osteomyelitis.8 
Concluding remarks 
Traditional classification systems have been 
extremely helpful to achieve our current state of 
knowledge. This review highlighted both the values 
and the limitations of these classification systems. It 
may reveal why they may not commonly be used in 
modern clinical practice. The reasons for this 
observation may include complexity of classification 
systems, classification systems that are too broad and 
those that have no definitive aim for clinical use. In 
our view some of the variables and definitions used 
are not helpful for the management of the disease in 
the context of modern diagnostic and management 
approaches. In addition, this review has 
demonstrated the lack of consensus in defining acute 
and chronic osteomyelitis, and that aetiopathogenesis 
is useful in describing the history of the disease but 
not a useful variable in a classification system.  
To propose a new and applicable classification 
system, these issues need to be addressed with a 
practical and clinical focus. In our view, the terms 
acute and chronic osteomyelitis and the variable 
aetiopathogenesis should be avoided in a future 
classification system. We suggest that the bone 
involvement, antimicrobial resistance patterns of 
causative micro-organisms, need for soft-tissue 
coverage and host status are important variables to 
include. Furthermore, they must be defined in a 
flexible way in order to remain valid alongside with 
medical progress.  
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